Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline in Chinese Parkinson's Patients with Motor Fluctuations
NCT01479530Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Dec 2011
- Primary completion
- Jun 2013
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Lundbeck. Started Dec 2011; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01479530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479530.